Last edition
News about "Red Herring Prospectus"
Senores Pharmaceuticals to Acquire Two ANDAs from Teva in USD 120 Million Market Opportunity
Senores Pharmaceuticals (SPL), through its wholly-owned US subsidiary Senores Pharmaceuticals, USA (SPI), has signed an agreement to acquire two USFDA-approved Abbreviated New Drug Applications (ANDAs) from Teva Pharmaceuticals USA.
Red Herring Prospectus | 13/08/2025 | By Darshana | 204
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members